Novartis Pays $25M To SEC In Chinese FCPA Case
Novartis AG will pay a $2 million penalty and $23 million in disgorgement and interest to settle U.S. Securities and Exchange Commission allegations that Chinese subsidiaries violated the Foreign Corrupt Practices...To view the full article, register now.
Already a subscriber? Click here to view full article